Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 72162-2499

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 72162-2499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622499)

Label for Sevelamer Carbonate 800 mg film-coated tablets, oral route, in a package of 270 tablets. The drug is relabeled by Bryant Ranch Prepack and manufactured by Macleods Pharmaceuticals Ltd. The label includes storage instructions and QR codes for prescribing information and package insert, along with the NDC 72162-2499-2 and a barcode.*

FDA Label Image

Sevelamer-car-structure (Sevelamer Carbonate Fig 1)

Chemical structure diagram of Sevelamer Carbonate showing its polymeric form with ammonium and bicarbonate groups, amino groups, and hydroxyl functional groups as part of the molecular structure.*

FDA Label Image

Figure-2 (Sevelamer Carbonate Fig 2)

A forest plot showing subgroup analyses for Sevelamer Carbonate compared to placebo. Subgroups include screening BSA, baseline serum phosphorus, age, and dialysis status. The graph plots mean differences with 95% confidence intervals, indicating effect sizes across various patient characteristics.*

FDA Label Image

Figure-3 (Sevelamer Carbonate Fig 3)

A line graph showing the percentage of patients with at least a 2 times reduction in serum phosphorus levels (mg/dL). The x-axis represents the reduction in serum phosphorus from baseline, ranging from worsened increase to improved reduction, while the y-axis shows the percentage of patients. Two lines compare Sevelamer Hydrochloride treatment with an active control.*

FDA Label Image

Figure-4 (Sevelamer Carbonate Fig 4)

Line graph showing phosphorus change from baseline over study weeks up to 52 weeks for two treatments: Sevelamer Hydrochloride and Active-Control. The x-axis represents study weeks, and the y-axis shows phosphorus change, with data points indicating trends for each treatment group over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.